Literature DB >> 27128531

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors.

Jacek Kubica1, Aldona Kubica2, Bernd Jilma3, Piotr Adamski4, Eva-Luise Hobl3, Eliano Pio Navarese5, Jolanta Maria Siller-Matula6, Anita Dąbrowska7, Tomasz Fabiszak1, Marek Koziński8, Paul Alfred Gurbel9.   

Abstract

Entities:  

Keywords:  Clopidogrel; Drug–drug interaction; Morphine; Prasugrel; Ticagrelor

Mesh：

Substances：

Year:  2016        PMID： 27128531     DOI： 10.1016/j.ijcard.2016.04.077

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  23 in total

1.  Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest.

Authors:  Julia M Umińska; Jakub Ratajczak; Katarzyna Buszko; Przemysław Sobczak; Wiktor Sroka; Michał P Marszałł; Piotr Adamski; Klemen Steblovnik; Marko Noč; Jacek Kubica
Journal:  Cardiol J       Date:  2019-02-25       Impact factor: 2.737

Review 2.  Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor.

Authors:  Ana Lucrecia Marcano; José Luis Ferreiro
Journal:  Curr Atheroscler Rep       Date:  2016-11       Impact factor: 5.113

3.  Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022.

Authors:  Jacek Kubica; Piotr Adamski; Jerzy R Ładny; Jarosław Kaźmierczak; Tomasz Fabiszak; Krzysztof J Filipiak; Robert Gajda; Mariusz Gąsior; Zbigniew Gąsior; Robert Gil; Jarosław Gorący; Stefan Grajek; Leszek Gromadziński; Marcin Gruchała; Grzegorz Grześk; Piotr Hoffman; Miłosz J Jaguszewski; Marianna Janion; Piotr Jankowski; Zbigniew Kalarus; Jarosław D Kasprzak; Andrzej Kleinrok; Wacław Kochman; Aldona Kubica; Wiktor Kuliczkowski; Jacek Legutko; Maciej Lesiak; Klaudiusz Nadolny; Eliano P Navarese; Piotr Niezgoda; Małgorzata Ostrowska; Przemysław Paciorek; Jolanta Siller-Matula; Łukasz Szarpak; Dariusz Timler; Adam Witkowski; Wojciech Wojakowski; Andrzej Wysokiński; Marzenna Zielińska
Journal:  Cardiol J       Date:  2022-05-06       Impact factor: 3.487

Review 4.  [Acute myocardial infarction in patients with ST-segment elevation myocardial infarction : ESC guidelines 2017].

Authors:  H Thiele; S Desch; S de Waha
Journal:  Herz       Date:  2017-12       Impact factor: 1.443

5.  A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study.

Authors:  Jacek Kubica; Piotr Adamski; Piotr Niezgoda; Aldona Kubica; Przemysław Podhajski; Malwina Barańska; Julia M Umińska; Łukasz Pietrzykowski; Małgorzata Ostrowska; Jolanta M Siller-Matula; Jolita Badarienė; Stanisław Bartuś; Andrzej Budaj; Sławomir Dobrzycki; Łukasz Fidor; Mariusz Gąsior; Jacek Gessek; Marek Gierlotka; Robert Gil; Jarosław Gorący; Paweł Grzelakowski; Tomasz Hajdukiewicz; Miłosz Jaguszewski; Marianna Janion; Jarosław Kasprzak; Adam Kern; Artur Klecha; Andrzej Kleinrok; Wacław Kochman; Bartosz Krakowiak; Jacek Legutko; Maciej Lesiak; Marcin Nosal; Grzegorz Piotrowski; Andrzej Przybylski; Tomasz Roleder; Grzegorz Skonieczny; Grzegorz Sobieszek; Agnieszka Tycińska; Dariusz Wojciechowski; Wojciech Wojakowski; Jarosław Wójcik; Marzenna Zielińska; Aleksander Żurakowski; Giuseppe Specchia; Diana A Gorog; Eliano P Navarese
Journal:  Cardiol J       Date:  2021-06-07       Impact factor: 2.737

6.  Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients.

Authors:  Jolanta M Siller-Matula; Simon Specht; Jacek Kubica; Dimitrios Alexopoulos; Raffaele De Caterina; Eva-Luise Hobl; Bernd Jilma; Günter Christ; Irene M Lang
Journal:  Br J Clin Pharmacol       Date:  2016-07-24       Impact factor: 4.335

7.  Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study.

Authors:  Piotr Adamski; Małgorzata Ostrowska; Joanna Sikora; Karolina Obońska; Katarzyna Buszko; Magdalena Krintus; Grażyna Sypniewska; Michał Piotr Marszałł; Marek Koziński; Jacek Kubica
Journal:  BMJ Open       Date:  2017-04-26       Impact factor: 2.692

8.  Pharmacokinetic Modeling of Morphine's Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers.

Authors:  Katarzyna Buszko; Krystian Kubica; Eva-Luise Hobl; Piotr Adamski; Kacper Wnuk; Bernd Jilma; Jacek Kubica
Journal:  Front Physiol       Date:  2021-06-24       Impact factor: 4.566

Review 9.  Ticagrelor - toward more efficient platelet inhibition and beyond.

Authors:  Michał J Kubisa; Mateusz P Jezewski; Aleksandra Gasecka; Jolanta M Siller-Matula; Marek Postuła
Journal:  Ther Clin Risk Manag       Date:  2018-01-17       Impact factor: 2.423

10.  Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients.

Authors:  K S Rathod; S Antoniou; P Avari; N Ding; P Wright; C Knight; A K Jain; A Mathur; E J Smith; R Weerackody; A Wragg; D A Jones
Journal:  JRSM Cardiovasc Dis       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.